Crabel Capital Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Crabel Capital Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-315,391	Closed	-$7.6M	–	130
2023 Q1	$7.6M	Buy	+315,391	New	+$3.96M	3.37%	6

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Crabel Capital Management's PRVB Position: Q2 2023 in Review

Crabel Capital Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 315,391 shares — an estimated $7.6M sold.

Crabel Capital Management first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $7.6M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Crabel Capital Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Crabel Capital Management sold 315,391 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $7.6M.
Crabel Capital Management first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Crabel Capital Management's Provention Bio, Inc. Common Stock position peaked at $7.6M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Crabel Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.